Install
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
New partnership to strengthen CAR-T cell therapy manufacturing capabilities in Japan
4+ hour, 11+ min ago (258+ words) BioSpectrum Asia New partnership to strengthen CAR-T cell therapy manufacturing capabilities in Japan September 13, 2026 | Sunday | News Teijin, Teijin Regenet and Shinshu University Hospital to contribute to the advancement of cell and gene therapies in Japan Teijin Limited, Teijin Regenet Co.,…...
Chad Rusthoven, MD, of the University of Colorado School of Medicine [IMAGE] | EurekAlert! Science News Releases
14+ hour, 56+ min ago (46+ words) Chad Rusthoven, MD, of the University of Colorado School of Medicine (IMAGE) EurekAlert! Chad Rusthoven, MD, of the University of Colorado School of Medicine More on this News Release Phase III MAVERICK trial supports brain MRI surveillance alone as standard…...
Giannis Mountzios, M.D., of the Henry Dunant Hospital Center, Athens, Greece [IMAGE] | EurekAlert! Science News Releases
13+ hour, 42+ min ago (43+ words) Giannis Mountzios, M.D., of the Henry Dunant Hospital Center, Athens, Greece (IMAGE) EurekAlert! Giannis Mountzios, M.D., of the Henry Dunant Hospital Center, Athens, Greece More on this News Release Sacituzumab govitecan plus pembrolizumab does not meet primary endpoints in first-line PD-L1-high…...
Aignostics Launches PathoSearch, a Visual Search Engine for Pathology Cases
1+ day, 10+ hour ago (386+ words) Now available via early access: image-based search retrieves real, diagnosed reference cases from world-class centers, spanning 300+ diagnostic entities. Now available via early access: image-based search retrieves real, diagnosed reference cases from world-class centers, spanning 300+ diagnostic entities.BERLIN and NEW YORK,…...
Akeso details survival win for its PD-1xVEGF drug versus Keytruda
18+ hour, 49+ min ago (76+ words) Endpoints News Akeso details survival win for its PD-1xVEGF drug versus Keytruda Akeso and Summit Therapeutics claimed a key win over Keytruda at the start of September,…...
Chemists Craft a One-Handed Molecule That Disarms a Cell-Death Protein
13+ hour, 39+ min ago (661+ words) A single protein called BAX sits at the gateway between life and death for human cells. When tissues are injured, stressed, or deprived of oxygen, BAX springs into action, punching holes in the outer membrane of mitochondria and triggering the…...
Receptor Occupancy Fails to Predict Immune Activation in Pembrolizumab
13+ hour, 50+ min ago (55+ words) Pembrolizumab, one of the most widely prescribed cancer immunotherapies in the world, has long been dosed on the assumption that saturating the PD-1 receptor on T cells is the key to unlocking the immune system against tumours. A new translational…...
Engineered T Cell Receptors With Built-In ICOS Deliver Long-Lasting
13+ hour, 57+ min ago (120+ words) Adoptive T cell therapy has delivered striking remissions in some blood cancers, but its promise in solid tumors has been repeatedly undermined by a stubborn problem: the therapeutic cells do not last. Engineered T cells that flood a tumor and…...
Scientists Flip the Drug Discovery Pipeline to Put Human Biology First in
14+ hour, 1+ min ago (704+ words) Cardiovascular medicine is quietly undergoing a structural rethink, and the change begins with the order of operations....
Chromosomal Chaos in Tumors May Blind the Immune System, Genome Study Finds
15+ hour, 25+ min ago (758+ words) Scientists in Japan have taken one of the most detailed looks yet at how large-scale genome disruption inside tumor cells may quietly rewire the immune landscape around them, and their findings could help explain why some cancers mount virtually no…...